ICIG Acquires Solvay Subsidary Belgium Based Peptides Manufacturer Peptisyntha SA For Pharmaceutical Use

ICIG acquires Peptisyntha from Solvay

5:12 AM, 29th August 2013
ICIG Business Acquisition News

FRANKFURT, GERMANY: International Chemical Investors Group (ICIG), a privately owned industrial holding company, will acquire Solvay’s subsidiary, Peptisyntha SA, the Brussels, Belgium, based custom manufacturer of peptides for pharmaceutical use. Upon closing of the deal, Peptisyntha will become a member of ICIG’s CordenPharma platform as its third site offering peptides manufacturing.

With the divestment of Peptisyntha, Solvay will focus on its core industrial activities, and completes the group’s exit from life science activities. As a CordenPharma member company, Peptisyntha will continue to execute its growth strategy, serving a wide range of applications and customers. While the US sister company Peptisyntha Inc, Torrance, California, is not part of the transaction, certain of its customer relationships will be assumed by Peptisyntha in Brussels.

“With Peptisyntha, we are adding industry-leading liquid phase synthesis capabilities and a team of highly skilled staff. Together with our solid-phase, hybrid synthesis, and development capacities at our sites in Boulder, Colorado, and Liestal, Switzerland, we will be in an excellent position to offer customers the full range of peptide synthesis strategies and services,” said Christian Ewers, Chief Operating Officer, API business, CordenPharma.

 

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Asahi Kasei to construct polycarbonatediol facility in China

TOKYO, JAPAN: Asahi Kasei Chemicals has decided to construct a plant in China for Duranol polycarbonatediol (PCD), an intermediate for high-performanc ...

Read more
Researchers find the reason for blood clotting disorder

HOUSTON, US: Research team at The University of Texas has found the variation that was causing the clotting problem in the case it wasn’t hemoph ...

Read more
ADM, CIC, Chemanex form bio-based SAP JV in Sri Lanka

COLOMBO, SRI LANKA: Archer Daniels Midland Company (ADM), CIC Holdings Plc and Chemanex Plc have formed a joint venture - Chemcel Pvt Ltd - that will ...

Read more
Saudi Aramco plans to acquire 30 pc stake in OPaL project

NEW DELHI, INDIA: The world’s biggest oil producer, Saudi Aramco, plans to acquire up to 30 per cent stake with a key management role in a giant ...

Read more
Statoil makes crude oil discovery offshore Canada

STAVANGER, NORWAY: Statoil has made a third discovery of crude oil in the Flemish Pass Basin, offshore Newfoundland. The discovery was made on the Bay ...

Read more
AkzoNobel appoints new head of integrated supply chain, David Allen

AMSTERDAM, THE NETHERLANDS: AkzoNobel appointed David Allen as the company’s new head of integrated supply chain, effective from 1 October 2013. ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X